Our Impact

Internationally, prevalence rates for HIV among injecting users are around 13%. In New Zealand, due largely to the early introduction of needle exchange and the work of the programme, prevalence rates are very low at 0.2%.

People injecting drugs are the most affected by hepatitis C with a national prevalence of 59%, and regional variance as high as 84%.

According to the 2013 Seroprevalence study, 69% of people injecting drugs report using a new needle every time.

Our aim is to ensure that people have access to sufficient new equipment for every injecting episode.

Online Store

You must be at least 16 years of age to use this site.